Assessment of Potential Adverse Events Following the 2022–2023 Seasonal Influenza Vaccines Among U.S. Adults Aged 65 Years and Older
Xiangyu (Chianti) Shi, Joann F. Gruber, Michelle Ondari, Patricia C. Lloyd, Pablo Freyria Duenas, Tainya C. Clarke, Gita Nadimpalli, Sylvia Cho, Laurie Feinberg, Mao Hu, Yoganand Chillarige, Jeffrey A. Kelman, Richard A. Forshee, Steven A. Anderson, Azadeh Shoaibi
doi: https://doi.org/10.1101/2023.09.20.23295817
